一个通用的Gompertz推广时间治愈模型及其适合癌症数据的适应性
Ayesha Tahira1, Muhammad Yameen Danish1
1Department of Statistics, AIOU, Islamabad, Pin 44000, Pakistan.
Heliyon
|June 24, 2024
概括
这项研究引入了一种新的通用Gompertz促进时间治疗模型,用于分析复杂的癌症存活数据. 该模型与标准模型相比,更适合长期幸存者.
科学领域:
- 生物统计学 生物统计学
- 生存分析的分析.
- 癌症研究 癌症研究
背景情况:
- 标准治愈模型 (指数,韦布尔,lognormal,戈珀茨,玛) 用于癌症临床试验的生存数据.
- 复杂的生存数据,特别是长期幸存者,经常显示与标准模型不匹配.
研究的目的:
- 介绍一个新的通用Gompertz推广时间治疗模型.
- 使用三种不同的方法评估模型对胃癌数据的适应性.
- 将广义的戈珀茨模型与现有分布进行比较.
主要方法:
- 开发一种全新的通用Gompertz推广时间治疗模型.
- 模型在真实胃癌患者数据上的应用和评估.
- 用了三种不同的方法来说明和比较健身.
主要成果:
- 拟议的通用Gompertz模型证明了对复杂的胃癌生存数据的良好适应性.
- 一般化的戈珀茨分布在计算上比一般化的F分布更不密集.
- 该模型为分析长期幸存者的癌症临床试验数据提供了一个可行的替代方案.
结论:
- 新的通用Gompertz推广治疗时间模型对于分析复杂的癌症存活数据是有效的.
- 与标准分布相比,这个模型提供了一个计算效率高,准确的方法.
- 这些发现支持在癌症临床试验中使用这种先进模型.
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Parametric Survival Analysis: Weibull and Exponential Methods
411
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
411
Kaplan-Meier Approach
129
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
129
Comparing the Survival Analysis of Two or More Groups
177
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
177
Survival Curves
131
Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
131
Assumptions of Survival Analysis
121
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
121


